Nelson Chao

President at American Society for Blood & Marrow Transplantation

Health Technology

Consumer Services

Profile

Nelson Chao is the founder of Aldagen, Inc., which was founded in 2000.
He held the title of Secretary from 2009 to 2012.
Currently, he holds the title of Principal at Duke University Medical Center and the title of President at American Society for Blood & Marrow Transplantation.

Nelson Chao active positions

Companies	Position	Start
Duke University Medical Center	Corporate Officer/Principal	-
American Society for Blood & Marrow Transplantation	President	-

All active positions of Nelson Chao

Former positions of Nelson Chao

Companies	Position	End
Aldagen, Inc. Aldagen, Inc. Pharmaceuticals: GenericHealth Technology Aldagen, Inc. develops and produces pharmaceutical products. It focuses on developing product candidates to address cardiovascular disease. The firm develops ALD-301 for the treatment of critical limb ischemia; ALD-201 for the treatment of ischemic heart failure; and ALD-401 for the post-acute treatment of ischemic stroke. The company also supplies ALDHbr cells for use in investigator-sponsored clinical studies. Aldagen was founded by Andrew E. Balber, Michael Sherman Colvin, Clay Smith and Nelson Chao in March 2000 and is headquartered in Durham, NC.	Founder	-

See the detail of Nelson Chao's experience

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Nelson Chao's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	2
Aldagen, Inc. Aldagen, Inc. Pharmaceuticals: GenericHealth Technology Aldagen, Inc. develops and produces pharmaceutical products. It focuses on developing product candidates to address cardiovascular disease. The firm develops ALD-301 for the treatment of critical limb ischemia; ALD-201 for the treatment of ischemic heart failure; and ALD-401 for the post-acute treatment of ischemic stroke. The company also supplies ALDHbr cells for use in investigator-sponsored clinical studies. Aldagen was founded by Andrew E. Balber, Michael Sherman Colvin, Clay Smith and Nelson Chao in March 2000 and is headquartered in Durham, NC.	Health Technology
American Society for Blood & Marrow Transplantation